Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive ...
Please provide your email address to receive an email when new articles are posted on . Identification of minimal residual disease using multiparameter flow cytometry following the first treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results